Tackling Antibiotic Resistance
- A mid-tier pharmaceutical company faced challenges due to the rising issue of antibiotic resistance
- With increasing instances of bacterial infections becoming resistant to existing antibiotics, the company needed to innovate and reposition its product portfolio to address this critical public health concern
- Understand antibiotic resistance impact, identify new antibiotic opportunities, and develop strategies for effective market entry and positioning of new or repositioned antibiotics
- Methodology:
- – Primary Research: Conducted 25 interviews with infectious disease specialists, microbiologists, and healthcare providers on antibiotic resistance trends and challenges
- – Secondary Research: Reviewed over 100 scientific articles, industry reports, and case studies on antibiotic development and resistance patterns
- Targeted Audience:
- – Infectious disease specialists, microbiologists, and healthcare providers for qualitative insights
- – Scientific literature and industry reports for secondary data analysis
- Initiated the development of two new antibiotics targeting multi-drug-resistant bacteria
- Successfully repositioned an existing antibiotic to address resistant strains, leading to a 20% increase in sales
- Formed strategic partnerships with leading research institutions to further antibiotic research and development
- Enhanced the company's reputation as a leader in innovative solutions for combating antibiotic resistance, attracting new investment opportunities
